Clinical Laboratory Improvement Advisory Committee (CLIAC); Cancellation of Meeting, 16945 [2020-06249]

Download as PDF 16945 Federal Register / Vol. 85, No. 58 / Wednesday, March 25, 2020 / Notices EXHIBIT 2—ESTIMATED ANNUALIZED COST BURDEN Number of interviews * Form name Average hourly wage rate ** Total burden hours Total cost burden PC CDS Learning Network—Leader ............................................................... PC CDS Learning Network—Governance/Non-Executive Steering Committee ............................................................................................................ PC CDS Learning Network—Contributor ........................................................ CDS Connect—Leader .................................................................................... CDS Connect—Contributor ............................................................................. CDS Connect—Consumer ............................................................................... CDS Connect—Participant .............................................................................. Quantifying Efficiencies—Leader ..................................................................... Quantifying Efficiencies—Informaticist ............................................................. Quantifying Efficiencies—Clinician .................................................................. PC CDS Projects –Site Leader ....................................................................... PC CDS Projects—Informaticist ...................................................................... PC CDS Projects—Clinician ............................................................................ PC CDS Projects—Patient .............................................................................. Web Survey of CDS Connect Users ............................................................... 7 7 1 $59.54 $416.78 3 8 5 20 25 10 5 4 8 18 10 20 4 453 3 8 5 20 25 10 5 4 8 18 10 20 4 77 1 59.54 2 59.54 178.62 476.33 297.71 1,190.82 1,488.53 595.41 297.71 238.16 811.46 1,071.74 595.40 2,028.60 99.93 4,584.66 Total .......................................................................................................... 600 224 ........................ 14,371.85 1 59.54 1 59.54 1 59.54 1 59.54 1 59.54 1 59.54 1 59.54 1 101.43 1 59.54 1 59.54 2 101.43 1 24.98 ** Wage rates were calculated using the mean hourly wage from the U.S. Department of Labor, Bureau of Labor Statistics, May 2018 National Occupational Employment and Wage Estimates for the United States, https://www.bls.gov/oes/current/oes_nat.htm. 1 Average rate for Computer Information and Research Scientists. 2 Average rate for Physicians and Surgeons. 3 Average rate for All Occupations. Request for Comments khammond on DSKJM1Z7X2PROD with NOTICES In accordance with the Paperwork Reduction Act, comments on AHRQ’s information collection are requested with regard to any of the following: (a) Whether the proposed collection of information is necessary for the proper performance of AHRQ’s health care research and health care information dissemination functions, including whether the information will have practical utility; (b) the accuracy of AHRQ’s estimate of burden (including hours and costs) of the proposed collection(s) of information; (c) ways to enhance the quality, utility and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information upon the respondents, including the use of automated collection techniques or other forms of information technology. Comments submitted in response to this notice will be summarized and included in the Agency’s subsequent request for OMB approval of the proposed information collection. All comments will become a matter of public record. Dated: March 19, 2020. Virginia L. Mackay-Smith, Associate Director. [FR Doc. 2020–06208 Filed 3–24–20; 8:45 am] BILLING CODE 4160–90–P VerDate Sep<11>2014 16:18 Mar 24, 2020 Jkt 250001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Clinical Laboratory Improvement Advisory Committee (CLIAC); Cancellation of Meeting Notice is hereby given of a change in the meeting of the Clinical Laboratory Improvement Advisory Committee (CLIAC); April 16, 2020, 8:30 a.m. to 5:00 p.m., EDT and April 17, 2020, 8:30 a.m. to 11:30 a.m., EDT, in the original FRN. Food and Drug Administration (FDA), White Oak Campus, 10903 New Hampshire Avenue, Building 31, Great Room, Silver Spring, Maryland 20993 and via webcast at www.cdc.gov/cliac which was published in the Federal Register on February 28, 2020, Volume 85, Number 40, page 11993. This meeting is being canceled in its entirety. FOR FURTHER INFORMATION CONTACT: Nancy Anderson, MMSc, MT(ASCP), Senior Advisor for Clinical Laboratories, Division of Laboratory Systems, Center for Surveillance, Epidemiology and Laboratory Services, Office of Public Health Scientific Services, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop V24–3, Atlanta, Georgia 30329–4027, telephone (404) 498–2741; NAnderson@cdc.gov. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been PO 00000 Frm 00021 Fmt 4703 Sfmt 4703 delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2020–06249 Filed 3–24–20; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Board of Scientific Counselors, National Center for Injury Prevention and Control, (BSC, NCIPC); Correction Notice is hereby given of a change in the meeting of the Board of Scientific Counselors, National Center for Injury Prevention and Control, (BSC, NCIPC); April 30, 2020, 12:30 p.m. to 3:50 p.m., EDT which was published in the Federal Register on February 24, 2020, Volume 85, Number 36, pages 10441– 10442. The SUMMARY should read as follows: SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting for the Board of Scientific Counselors, National Center for Injury Prevention and Control, (BSC, NCIPC). This E:\FR\FM\25MRN1.SGM 25MRN1

Agencies

[Federal Register Volume 85, Number 58 (Wednesday, March 25, 2020)]
[Notices]
[Page 16945]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-06249]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Clinical Laboratory Improvement Advisory Committee (CLIAC); 
Cancellation of Meeting

    Notice is hereby given of a change in the meeting of the Clinical 
Laboratory Improvement Advisory Committee (CLIAC); April 16, 2020, 8:30 
a.m. to 5:00 p.m., EDT and April 17, 2020, 8:30 a.m. to 11:30 a.m., 
EDT, in the original FRN. Food and Drug Administration (FDA), White Oak 
Campus, 10903 New Hampshire Avenue, Building 31, Great Room, Silver 
Spring, Maryland 20993 and via webcast at www.cdc.gov/cliac which was 
published in the Federal Register on February 28, 2020, Volume 85, 
Number 40, page 11993.
    This meeting is being canceled in its entirety.

FOR FURTHER INFORMATION CONTACT: Nancy Anderson, MMSc, MT(ASCP), Senior 
Advisor for Clinical Laboratories, Division of Laboratory Systems, 
Center for Surveillance, Epidemiology and Laboratory Services, Office 
of Public Health Scientific Services, Centers for Disease Control and 
Prevention, 1600 Clifton Road NE, Mailstop V24-3, Atlanta, Georgia 
30329-4027, telephone (404) 498-2741; [email protected].
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-06249 Filed 3-24-20; 8:45 am]
BILLING CODE 4163-18-P